These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26104147)

  • 21. Various regimens for prophylactic treatment of patients with haemophilia.
    Schwarz R; Ljung R; Tedgård U
    Eur J Haematol; 2015 Feb; 94 Suppl 77():11-6. PubMed ID: 25560789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of central venous access devices in paediatric haemophilia patients.
    Domm JA; Hudson MG; Janco RL
    Haemophilia; 2003 Jan; 9(1):50-6. PubMed ID: 12558778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis Study.
    Feldman BM; Pai M; Rivard GE; Israels S; Poon MC; Demers C; Robinson S; Luke KH; Wu JK; Gill K; Lillicrap D; Babyn P; McLimont M; Blanchette VS;
    J Thromb Haemost; 2006 Jun; 4(6):1228-36. PubMed ID: 16706965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central venous access devices in children with hemophilia: an update.
    Blanchette VS; Al-Musa A; Stain AM; Ingram J; Fille RM
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S11-4. PubMed ID: 9351530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
    McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
    Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arteriovenous shunts as venous access in children with haemophilia.
    Thom KE; Hölzenbein T; Jones N; Zwiauer K; Streif W; Gattringer S; Male C
    Haemophilia; 2018 May; 24(3):429-435. PubMed ID: 29573510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
    Ullman AJ; Cooke M; Kleidon T; Rickard CM
    J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.
    Neunert CE; Miller KL; Journeycake JM; Buchanan GR
    Haemophilia; 2008 Mar; 14(2):260-70. PubMed ID: 18179577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of central venous catheters in haemophilia patients.
    Izzi G; Franchini M; Bonetti L; Tagliaferri A
    Haemophilia; 2010 Jan; 16 Suppl 1():29-31. PubMed ID: 20059567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis.
    Ragni MV; Journeycake JM; Brambilla DJ
    Haemophilia; 2008 Jan; 14(1):30-8. PubMed ID: 18005145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
    Tarantino MD; Lail A; Donfield SM; Lynn H; Peddle L; Hunsberger S; Shapiro AD
    Haemophilia; 2003 Sep; 9(5):588-92. PubMed ID: 14511299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
    Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
    Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous access in haemophilic children: choice and management.
    Santagostino E; Mancuso ME
    Haemophilia; 2010 Jan; 16 Suppl 1():20-4. PubMed ID: 20059565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Routine Preprocedural Bloodwork Needed for Elective Central Venous Access Device Removals in Children without Bleeding Dyscrasias?
    Donnellan J; Smith CE; John P; Amaral JG
    J Vasc Interv Radiol; 2020 Feb; 31(2):276-281.e1. PubMed ID: 31883934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature.
    Swan D; Paran S; Nolan B
    Haemophilia; 2022 Jan; 28(1):42-45. PubMed ID: 34786787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric central venous access devices: practice, performance, and costs.
    Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
    Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
    Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
    Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study.
    Hilliard P; Zourikian N; Blanchette V; Chan A; Elliott B; Israels SJ; Nilson J; Poon MC; Laferriere N; Van Neste C; Jarock C; Wu J; McLimont M; Feldman B
    J Thromb Haemost; 2013 Mar; 11(3):460-6. PubMed ID: 23301594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.